News | October 03, 2023
Solvay celebrates Medicine Nobel Prize winner Katalin Karikó
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
Bertozzi currently serves as the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor at Stanford University, and Investigator of the Howard Hughes Medical Institute
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
The Phase IV DREAM-CKD trial will enrol 1004 CKD patients in India, including 502 dialysis dependent, 502 dialysis independent CKD patients with anemia.
Subscribe To Our Newsletter & Stay Updated
